Bio-Rad Laboratories Inc (BIO)
325.58
+1.89
(+0.58%)
USD |
NYSE |
Nov 21, 16:00
325.57
-0.01
(-0.00%)
Pre-Market: 20:00
Bio-Rad Laboratories Market Cap: 9.115B for Nov. 21, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| November 21, 2024 | 9.115B |
| November 20, 2024 | 9.062B |
| November 19, 2024 | 8.977B |
| November 18, 2024 | 8.767B |
| November 15, 2024 | 8.968B |
| November 14, 2024 | 9.805B |
| November 13, 2024 | 10.17B |
| November 12, 2024 | 10.21B |
| November 11, 2024 | 10.25B |
| November 08, 2024 | 10.34B |
| November 07, 2024 | 10.44B |
| November 06, 2024 | 10.44B |
| November 05, 2024 | 10.48B |
| November 04, 2024 | 10.33B |
| November 01, 2024 | 10.31B |
| October 31, 2024 | 10.03B |
| October 30, 2024 | 9.255B |
| October 29, 2024 | 9.285B |
| October 28, 2024 | 9.199B |
| October 25, 2024 | 8.965B |
| October 24, 2024 | 9.185B |
| October 23, 2024 | 9.381B |
| October 22, 2024 | 9.514B |
| October 21, 2024 | 9.606B |
| October 18, 2024 | 9.697B |
| Date | Value |
|---|---|
| October 17, 2024 | 9.630B |
| October 16, 2024 | 9.233B |
| October 15, 2024 | 9.579B |
| October 14, 2024 | 9.548B |
| October 11, 2024 | 9.432B |
| October 10, 2024 | 9.334B |
| October 09, 2024 | 9.480B |
| October 08, 2024 | 9.497B |
| October 07, 2024 | 9.547B |
| October 04, 2024 | 9.622B |
| October 03, 2024 | 9.437B |
| October 02, 2024 | 9.592B |
| October 01, 2024 | 9.454B |
| September 30, 2024 | 9.367B |
| September 27, 2024 | 9.247B |
| September 26, 2024 | 9.256B |
| September 25, 2024 | 8.795B |
| September 24, 2024 | 9.139B |
| September 23, 2024 | 9.103B |
| September 20, 2024 | 9.198B |
| September 19, 2024 | 9.604B |
| September 18, 2024 | 9.489B |
| September 17, 2024 | 9.299B |
| September 16, 2024 | 9.205B |
| September 13, 2024 | 9.092B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
7.444B
Minimum
Jul 01 2024
24.59B
Maximum
Sep 02 2021
14.01B
Average
13.69B
Median
Market Cap Benchmarks
| Agilent Technologies Inc | 37.94B |
| Bruker Corp | 8.523B |
| Azenta Inc | 2.075B |
| Harvard Bioscience Inc | 94.21M |
| Bionano Genomics Inc | 22.35M |
Market Cap Related Metrics
| PS Ratio | 3.587 |
| PEG Ratio | -0.0324 |
| Price to Book Value | 1.217 |
| Price to Free Cash Flow | 41.36 |
| Price | 325.58 |
| Earnings Yield | -8.39% |
| PEGY Ratio | -0.0324 |
| Operating PE Ratio | 30.25 |
| Normalized PE Ratio | 34.52 |